Open Access Articles- Top Results for Aurobindo Pharma

Aurobindo Pharma

Aurobindo Pharma Limited
Industry Pharmaceuticals
Founded 1986
Headquarters Hyderabad, Telengana, India
Key people
P.V.Ramprasad Reddy, K. Nithyananda Reddy, Dr. M. Sivakumaran, Mr. Madanmohan Reddy, Mr. Govind, Mr. Arvind Vasudeva,
Products Formulation, Active Pharmaceutical Ingredient, Organic Intermediates

Aurobindo Pharma Limited is a pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s area of activity includes six major therapeutic/product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics.[citation needed] The company markets these products in over 125 countries.[citation needed] Its marketing partners include AstraZeneca[1] and Pfizer.[2]


The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins[citation needed], it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.

Aurobindo Pharma features among the top 10 companies in India in terms of consolidated revenues.[citation needed] Aurobindo exports to over 125 countries across the globe with more than 70% of its revenues derived out of international operations.

In 2014, Aurobindo purchased the generic operations of Actavis in 7 Western European countries for $41 million.[3] [4]


  1. ^ "Aurobindo Pharma signs supply pact with AstraZeneca", Economic Times, September 6, 2010
  2. ^ "Pfizer, Astra deals to drive Aurobindo Pharma’s growth", Economic Times, November 5, 2010
  3. ^ "Aurobindo Buys Actavis' European Operations". News: Industry Watch. Gen. Eng. Biotechnol. News (paper) 34 (4). 15 February 2014. p. 10. 
  4. ^ "Aurobindo To Buyout Actavis' EU Ops". Bloomberg TV India. Retrieved 20 January 2014. 

External links